Home > Insider Trading > Filing (0001493152-23-005080)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1695357	Provention Bio Inc.	PRVB	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1728920	Francisco Leon	C/O Provention Bio, Inc. 55 Broad Street, 2Nd Floor Red Bank NJ 07701	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-02-10	50,000	$2.50	1,623,000	No	4	M	Direct
Common Stock	Disposition	2023-02-10	50,000	$10.11	1,573,000	No	4	S	Direct
Common Stock	Acquisiton	2023-02-13	25,985	$2.50	1,598,985	No	4	M	Direct
Common Stock	Disposition	2023-02-13	25,985	$10.04	1,573,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2023-02-10	50,000	$0.00	50,000	$2.50
Common Stock	Stock Option (right to buy)	Disposition	2023-02-13	25,985	$0.00	25,985	$2.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
268,088		2027-04-25	No	4	M	Direct
242,103		2027-04-25	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,000,000	Indirect	By Trust

Footnotes

The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2022.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.29 per share, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.42 per share, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
The option is fully vested.